SLC12A2 and nervous system disorder: Targeting SPAK kinases is a powerful way of regulating Cl– as it can simultaneously inhibit NKCC1 and activate KCC2 (Huang et al., 2019), thus proving to be an effective approach to modulate CCCs for various neurological disorders.